Your browser doesn't support javascript.
loading
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.
Falchi, L; Kantarjian, H M; Verstovsek, S.
Affiliation
  • Falchi L; Department of Medicine, Division of Hematology/Oncology, New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 31(9): 1845-1854, 2017 09.
Article in En | MEDLINE | ID: mdl-28529308
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Genomics / Thrombocythemia, Essential Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Genomics / Thrombocythemia, Essential Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: United States